InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Hamill Laura, 董事. Officer active across 3 companies, notably Acceleron Pharma INC. In total, 8 filings have been logged. Activity tracked since 8 June 2023. The latest transaction was filed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Hamill Laura is Administrateur at Y-mAbs Therapeutics, Inc., Jazz Pharmaceuticals plc and Acceleron Pharma INC. She has 8 filings in total, and across the 8 recent filings available, the modal transaction nature is Attribution, with buy and sell amounts of EUR 0. The observed period runs from 2021-11-22 to 2026-08-07.